Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Interim Management Statement

11 May 2010 07:00

RNS Number : 6646L
Huntsworth PLC
11 May 2010
 



 

11 May 2010

 

 

Huntsworth plc

("Huntsworth" or "the Group")

Interim Management Statement

Net New Business Up 33%; 80% Committed Revenues for 2010; Largest ever win for Grayling confirmed.

 

Huntsworth plc, the global public relations and healthcare communications group, reports significantly higher net new business activity in Q1 of 2010 compared with Q1 2009.

 

Net new business wins were up 33% on a like for like basis and the Group now has committed revenues of 80% against its rising revenues targets for 2010. The Group is trading in line with management revenue and profit expectations and expects to return to revenue growth during the summer.

 

The balance sheet remains robust with net debt comfortably within banking covenants.

 

Following the confirmation of the liquidity thresholds announced by FTSE on 1 April, Huntsworth believes that it may qualify for the FTSE All-Share index in the next annual review to be held on 9 June 2010.

 

 

Peter Chadlington, Huntsworth's Chief Executive, commented:

"I am very encouraged by this good start to the year. Despite the low comparator base of the previous year, the strong new business flow we have seen in the first quarter of 2010, the level of revenues already committed for the full year and our growing ability to win bigger and more international mandates gives us confidence that Huntsworth will not only return to growth during 2010 but also that we are on track to meet our ambitious target of doubling our historic organic growth record during 2011."

 

 

From this year the Group will be reporting results and Interim Management Statements by each of its four brands.

 

CITIGATE

 

The stronger financial markets have brought real impetus to the Citigate division with new business 51% ahead of 2009 on a like for like basis. Committed revenues are now at 76% of full year forecasts.

 

Recent transactional work includes advising Tullow Oil on its acquisition of assets in Uganda, Investec Bank plc on its successful acquisition of Rensburg Sheppards and the first two Russian companies to list in Russia in 2010, Protek and Russian Sea. Other wins include easyGroup, the private investment vehicle of Sir Stelios Haji-Ioannou, Spyker, the Dutch car maker that recently saved Swedish Saab, and the launch of the UK based law firm Wragge & Co in France.

 

GRAYLING

 

Following the rebranding, pitching activity has been very high. 80% of 2010 revenues are now committed with new business 25% ahead of Q1 2009 on a like for like basis. Grayling has won a number of significant multi-office, international accounts with further significant opportunities in the pipeline.

 

Grayling won its largest client to date - The Portuguese Cork Association (APCOR) - with a seven figure fee. The assignment is a major international communications programme to promote the advantages of cork stoppers and cork building and decoration materials in six key markets: the UK, Italy, China, Japan, Russia and the United Arab Emirates. Grayling won this account following an extensive international public tender.

 

Grayling has also been successful in winning a number of other high profile international clients including the Nabucco Gas Pipeline, Sony Pictures Television in the Baltic States and a retained contract from The Economist Group in Germany, Turkey, Italy and Spain. Grayling has also been appointed to work on My Hermes, a campaign that targets the ebay market and Lyle & Scott which extends Grayling's digital work across a number of European markets.

 

These recent successes add to Grayling's earlier global wins announced in February of Lloyds International Private Banking and The International Federation of Animal Health Companies.

 

Dutko Worldwide was acquired at the end of 2009 and has been engaged in over two dozen transatlantic international business opportunities since joining the Grayling division.

 

HUNTSWORTH HEALTH

 

Huntsworth Health continues to build on its strong 2009 growth rate with new business in the quarter 40% ahead of the first quarter of 2009 on a like for like basis, and committed revenues are now at 79% of full year budgets. Digital revenues, which grew 100% in 2009 and now represent 15% of the division's revenues, have grown by a further 100% in the first quarter of 2010.

 

Recent wins include Napp Pharmaceuticals to prepare for the launch of a new treatment in the respiratory arena and BiogenIDEC who have engaged an integrated team across disciplines to work on a major mobility initiative in multiple sclerosis.

 

RED

 

After an outstanding organic growth record in 2009, new business in the first quarter at RED is 13% ahead of 2009 and full year revenues are now 88% committed.

 

Recent wins include Avis and Budget, the UK PR communications for both brands; Kelkoo, Pan-EMEA and UK strategic planning and activity for the European shopping comparison website; Health & Safety Executive, an awareness campaign to help reduce the numbers of deaths and injuries to farmers and Mundipharma, the European launch of a new rheumatoid arthritis treatment.

 

Note : Like-for-like new business includes pre-acquisition performance and is stated at constant currencies.

 

Enquiries to:

 

Huntsworth PLC +44 (0)207 224 8778

Peter Chadlington, Group Chief Executive

Sally Withey, Chief Operating Officer

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Simon Rigby

George Cazenove

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKKDQABKDOPD
Date   Source Headline
12th May 20152:18 pmRNSDirector/PDMR Shareholding
5th May 201510:08 amRNSHolding(s) in Company
30th Apr 20154:26 pmRNSAnnual Financial Report
28th Apr 20153:57 pmRNSDirector/PDMR Shareholding
21st Apr 20153:10 pmRNSDirector/PDMR Shareholding
20th Apr 20151:07 pmRNSDirector/PDMR Shareholding
10th Apr 20157:00 amRNSAudited Preliminary Results
10th Mar 20154:02 pmRNSHuntsworth plc - Notice of Preliminary Results
12th Feb 201511:03 amRNSChief Executive Update
2nd Feb 20152:07 pmRNSTotal Voting Rights
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
22nd Dec 20142:54 pmRNSDirector/PDMR Shareholding
22nd Dec 201411:21 amRNSAppointment of new Chief Executive
19th Dec 20144:21 pmRNSDirector Declaration
19th Dec 201411:25 amRNSDirectorate Change
15th Dec 20144:35 pmRNSPrice Monitoring Extension
9th Dec 201410:06 amRNSHolding(s) in Company
5th Dec 20144:40 pmRNSSecond Price Monitoring Extn
5th Dec 20144:35 pmRNSPrice Monitoring Extension
1st Dec 201412:03 pmRNSBlocklisting Interim Review
20th Nov 20144:21 pmRNSDirectorate Change
3rd Nov 20149:31 amRNSTotal Voting Rights
28th Oct 20149:30 amRNSAdditional Listing
8th Oct 201410:09 amRNSDividend Declaration
7th Oct 20143:15 pmRNSDirectorate Change
1st Sep 20149:32 amRNSTotal Voting Rights
11th Aug 20144:56 pmRNSDirector/PDMR Shareholding - Replacement
11th Aug 20142:05 pmRNSDirector Declaration
11th Aug 20141:08 pmRNSDirector/PDMR Shareholding
11th Aug 20147:00 amRNSInterim results for the six months to 30 June 2014
6th Aug 20148:51 amRNSNotice of Results
1st Aug 201410:18 amRNSTotal Voting Rights
31st Jul 20143:08 pmRNSHolding(s) in Company
14th Jul 201410:10 amRNSDirector Update
14th Jul 20147:00 amRNSHuntsworth Trading Update
7th Jul 20149:36 amRNSHolding(s) in Company
3rd Jul 201412:34 pmRNSAdditional Listing
26th Jun 20149:16 amRNSNotification of Board Changes
25th Jun 20143:32 pmRNSHolding(s) in Company
24th Jun 201411:33 amRNSResult of AGM
4th Jun 20142:38 pmRNSScript Dividend Alternative
3rd Jun 201412:13 pmRNSBlocklisting Interim Review
27th May 20149:37 amRNSNotice of AGM
16th May 20142:59 pmRNSInterim Management Statement
2nd May 20141:51 pmRNSDirector/PDMR Shareholding
30th Apr 20143:31 pmRNSAnnual Financial Report
29th Apr 20147:00 amRNSAudited Preliminary Results 2013
28th Apr 20147:00 amRNSNotification of Board Changes
25th Apr 201410:51 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.